ロード中...

Treatment of hyperprolactinaemia reduces total cholesterol and LDL in patients with prolactinomas

Previous studies suggest that hyperprolactinaemia might have adverse effects on lipid and glucose metabolism. We therefore aimed to evaluate whether dopamine agonist treatment with cabergoline has significant effects on blood lipids, fasting glucose and HbA1c levels in patients with micro- or macrop...

詳細記述

保存先:
書誌詳細
出版年:Metab Brain Dis
主要な著者: Schwetz, Verena, Librizzi, Rosaria, Trummer, Christian, Theiler, Georg, Stiegler, Claudia, Pieber, Thomas R., Obermayer-Pietsch, Barbara, Pilz, Stefan
フォーマット: Artigo
言語:Inglês
出版事項: Springer US 2016
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5566581/
https://ncbi.nlm.nih.gov/pubmed/27525431
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11011-016-9882-2
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!